Navigation
Hair Loss News Archives
August 2005
Panacea
Biotec in-licenses novel technology for hair growth
Panacea Biotec Ltd on Tuesday said that, it
has in licensed a peptide based technology for alopecia (Hait Loss leading to
Baldness) management from the National Institute of Health, USA. The patent
protected technology for actin-binding peptide( s) /poly peptide (s) stimulates
hair growth and regenerates lost hair follicles.
Rajesh Jam, Joint Managing Director, of the Company stated, "In line with our mission to deliver innovative health management solutions we are working with top global institutions to develop novel technology based products.
The patented technology from NIH provides the basis for development of safe and effective treatment for hair loss, which is a huge problem worldwide."
The Company said that, it will undertake further development of the technology and the Company is initiating the pre-clinical toxicology studies for which the appropriate formulation has already been prepared.
After receiving the necessary regulatory approvals for the toxicology data that will be generated, the human clinical trials for the product will be undertaken, the Company said.